Log in to your Inderes Free account to see all free content on this page.
Nanologica
1.895
SEK
-1.56 %
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 following
-1.56%
+4.12%
-18.49%
-67.29%
-80.94%
-80.1%
-84.75%
-81.01%
-89.55%
Nanologica is a life science tools company that develops, manufactures and sells advanced consumables to pharmaceutical companies. Nanologica's silica-based products are specially designed for the purification of peptide drugs, such as insulin and GLP-1 analogs. Nanologica operates in a global niche market for medicines for the treatment of diabetes and obesity. Nanologica was founded in 2004 and has its headquarters in Södertälje.
Read moreMarket cap
167.44M SEK
Turnover
72.95K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
7.2.
2025
Annual report '24
17.4.
2025
Interim report Q1'25
22.5.
2025
General meeting '24
ShowingAll content types
Number of Shares and Votes in Nanologica AB (publ)
Redeye: Nanologica Q3 2024 - Poised for harvest season?
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio